Last updated on June 2020

Efficacy Safety and Tolerability of AVP-786 for the Treatment of Negative Symptoms of Schizophrenia


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Schizophrenia and Schizoaffective Disorders | Schizophrenia and Schizoaffective Disorders (Pediatric) | Schizophrenia
  • Age: Between 18 - 60 Years
  • Gender: Male or Female

Inclusion Criteria:

  • Participants who meet the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-V) diagnostic criteria for schizophrenia confirmed by the Mini International Neuropsychiatric Interview (M.I.N.I) Version 7.0.2
  • Participants must meet Positive and Negative Syndrome Scale (PANSS) criteria
  • Participants currently receiving a second-generation atypical antipsychotic drug (SGA) are eligible provided they are on a stable dose

Exclusion Criteria:

  • Participants with current major depressive disorder (MDD)
  • Participants with pseudo-parkinsonism secondary to their ongoing antipsychotic medication
  • Participants currently using anticholinergic medications
  • Participants recently hospitalized as in-patients

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.